Average Co-Inventor Count = 6.07
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Texas System (22 from 5,444 patents)
2. Merck Sharp + Dohme Corp. (10 from 2,405 patents)
3. Chempartner Corporation (7 from 7 patents)
4. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa (3 from 47 patents)
5. Merck Canada Inc. (3 from 40 patents)
6. Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.r.l. (1 from 4 patents)
7. Istituto Di Ricerche Di Biologia P. Angeletti S.p.a. (1 from 1 patent)
36 patents:
1. 12036231 - Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
2. 11958849 - GLS1 inhibitors for treating disease
3. 11725008 - Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
4. 11434233 - Heterocyclic inhibitors of ATR kinase
5. 11400108 - Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
6. 11370786 - GLS1 inhibitors for treating disease
7. 11028083 - Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
8. 11001594 - Heterocyclic modulators of HIF activity for treatment of disease
9. 10933078 - Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
10. 10894052 - Heterocyclic inhibitors of ATR kinase
11. 10888554 - Salts of heterocyclic modulators of HIF activity for treatment of disease
12. 10800769 - Heterocyclic inhibitors of ATR kinase
13. 10800774 - Heterocyclic inhibitors of ATR kinase
14. 10766892 - GLS1 inhibitors for treating disease
15. 10745420 - Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase